For instance, the frequency of MAGE-A4 expression was observed in 50% of head and neck squamous cell carcinomas, 24% of non-small-cell lung cancers, and 60% of esophageal cancers [24]. Here, MAGEA4 is linked to non-small cell lung carcinoma.